PCN19 AUSTRALIAN COST-EFFECTIVENESS ANALYSIS OF ANASTROZOLEVSTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67257-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67257-9/fulltext
Title :
PCN19 AUSTRALIAN COST-EFFECTIVENESS ANALYSIS OF ANASTROZOLEVSTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67257-9&doi=10.1016/S1098-3015(10)67257-9
First page :
Section Title :
Open access? :
No
Section Order :
484